Addiphos concentrate for solution for infusion
Authorisation PA2059/024/001 · Fresenius Kabi Deutschland GmbH
- Licence holder
- Fresenius Kabi Deutschland GmbH (all products →)
- Active substances
- Potassium dihydrogen phosphate, Potassium hydroxide, Disodium phosphate dihydrate
- Dosage form
- Concentrate for solution for infusion
- Route of administration
- Intravenous use
- ATC codes
- B05XA, B05XA30
- First authorised
- 01/04/1983
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Full application (Article 8(3) of Directive No 2001/83/EC)
Potassium dihydrogen phosphate: supply and approvals
2 authorised products on the HPRA list contain Potassium dihydrogen phosphate. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 20 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 20 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 20 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
Potassium hydroxide: supply and approvals
1 authorised product on the HPRA list contains Potassium hydroxide. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 20 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 20 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 20 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
Disodium phosphate dihydrate: supply and approvals
4 authorised products on the HPRA list contain Disodium phosphate dihydrate. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 20 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 20 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 20 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 43 years (since 1 April 1983). The HPRA list marks it as marketed in Ireland.
Other medicines with Potassium dihydrogen phosphate in Ireland
4 other products on the HPRA list contain Potassium dihydrogen phosphate, from 1 licence holder; 1 of them is marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Potassium Phosphate 1mmol/ml + 0.6mmol/ml Concentrate for Solution for Infusion | B. Braun Melsungen AG | National authorisation (PA) | Marketed |
| Nutriflex basal solution for infusion | B. Braun Melsungen AG | National authorisation (PA) | Not marketed |
| Nutriflex peri solution for infusion | B. Braun Melsungen AG | National authorisation (PA) | Not marketed |
| Nutriflex special solution for infusion | B. Braun Melsungen AG | National authorisation (PA) | Not marketed |
Other medicines with Potassium hydroxide in Ireland
4 other products on the HPRA list contain Potassium hydroxide, from 1 licence holder; 0 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Nutriflex basal solution for infusion | B. Braun Melsungen AG | National authorisation (PA) | Not marketed |
| Nutriflex peri solution for infusion | B. Braun Melsungen AG | National authorisation (PA) | Not marketed |
| Nutriflex plus solution for infusion | B. Braun Melsungen AG | National authorisation (PA) | Not marketed |
| Nutriflex special solution for infusion | B. Braun Melsungen AG | National authorisation (PA) | Not marketed |
Other substances in ATC group B05XA
The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 23 other active substances share the group B05XA with this product:
Sodium chloride (6) · Potassium chloride (4) · Potassium iodide (3) · Sodium fluoride (2) · Sodium selenite anhydrous (2) · Zinc chloride (2) · Sodium bicarbonate (1) · Chromic chloride hexahydrate (1) · Copper chloride dihydrate (1) · Ferric chloride hexahydrate (1) · Manganese chloride tetrahydrate (1) · Sodium molybdate dihydrate (1) · Calcium chloride dihydrate (1) · Zinc gluconate (1) · Copper gluconate (1) · Manganese Gluconate (1) · Sodium selenite (1) · Magnesium sulphate heptahydrate (1) · Copper chloride 2H2O (1) · Manganese chloride 4H2O (1) · and 3 more
Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.
The licence holder
Fresenius Kabi Deutschland GmbH holds 164 products on the HPRA list, with 164 different active substances; 69 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 21 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.